Building innovations from ORNL will be on display in Washington, D.C. on the National Mall June 7 to June 9, 2024, during the U.S. Department of Housing and Urban Development’s Innovation Housing Showcase. For the first time, ORNL’s real-time building evaluator was demonstrated outside of a laboratory setting and deployed for building construction.
Scientists have uncovered the properties of a rare earth element that was first discovered 80 years ago at the very same laboratory, opening a new pathway for the exploration of elements critical in modern technology, from medicine to space travel.
Two different teams that included Oak Ridge National Laboratory employees were honored Feb. 20 with Secretary’s Honor Achievement Awards from the Department of Energy. This is DOE's highest form of employee recognition.
ORNL and Tuskegee University have formed a partnership to develop new biodegradable materials for use in buildings, transportation and biomedical applications.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
Researchers at ORNL designed a novel polymer to bind and strengthen silica sand for binder jet additive manufacturing, a 3D-printing method used by industries for prototyping and part production.
Amy Elliott, a group leader for robotics and intelligent systems at Oak Ridge National Laboratory, has received the 2021 ASTM International Additive Manufacturing Young Professional Award for her early career research contributions
Six science and technology innovators from across the United States will join the fifth cohort of Oak Ridge National Laboratory’s Innovation Crossroads program in June.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.